Ardelyx (ARDX) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -11.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.99% |
| Dec 31, 2025 | -26.79% |
| Sep 30, 2025 | 65.15% |
| Jun 30, 2025 | 10.86% |
| Mar 31, 2025 | -13.59% |
| Dec 31, 2024 | 28.63% |
| Sep 30, 2024 | 73.52% |
| Jun 30, 2024 | 28.59% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | 0.09% |
| Sep 30, 2023 | 33.25% |
| Jun 30, 2023 | 11.80% |
| Mar 31, 2023 | -6.17% |
| Dec 31, 2022 | 36.45% |
| Sep 30, 2022 | 0.92% |
| Jun 30, 2022 | -1.89% |
| Mar 31, 2022 | -2.40% |
| Dec 31, 2021 | -9.15% |
| Sep 30, 2021 | -21.79% |
| Jun 30, 2021 | -26.56% |
| Mar 31, 2021 | -24.89% |
| Dec 31, 2020 | -69.33% |
| Sep 30, 2020 | 4.40% |
| Jun 30, 2020 | 1.00% |
| Mar 31, 2020 | 7.21% |
| Dec 31, 2019 | 14.15% |
| Sep 30, 2019 | 6.75% |
| Jun 30, 2019 | 3.81% |
| Mar 31, 2019 | -3.67% |
| Dec 31, 2018 | -17.90% |
| Sep 30, 2018 | -10.00% |
| Jun 30, 2018 | -64.79% |
| Mar 31, 2018 | -69.38% |
| Dec 31, 2017 | 65.68% |
| Sep 30, 2017 | -555.81% |
| Jun 30, 2017 | -106.87% |
| Mar 31, 2017 | -108.93% |
| Dec 31, 2016 | -94.22% |
| Sep 30, 2016 | -214.42% |
| Jun 30, 2016 | -217.85% |